RHEUM || Spondyloarthropathies

Golimumab effective against nonradiographic axial spondyloarthritis with inflammation

Posted on: 26/11/2014 - 15:16

BOSTON – Golimumab was significantly better than placebo at reducing disease activity and inflammation in patients with nonradiographic axial spondyloarthritis, but only among those who were positive...

Field of Interest: Rheumatology

Type: News Item

Axial spondyloarthropathy guidelines: NSAIDs and PT first

Posted on: 20/11/2014 - 16:57

BOSTON – A nonsteroidal anti-inflammatory drug and exercise may be enough to control active axial spondyloarthritis in some patients, suggest authors of draft guidelines on the management of patients...

Field of Interest: Rheumatology

Type: News Item

Certolizumab achieves sustained skin improvement in psoriatic arthritis

Posted on: 17/11/2014 - 17:27

AMSTERDAM – Certolizumab pegol maintained significant improvement in dermatologic outcomes in psoriatic arthritis patients through 96 weeks of treatment in the phase III RAPID-PsA trial. Moreover,...

Field of Interest: Dermatology

Type: News Item

Certolizumab achieves sustained skin improvement in psoriatic arthritis

Posted on: 17/11/2014 - 17:27

Field of Interest: Rheumatology

Type: News Item

Apremilast succeeds against nail, scalp, palmoplantar psoriasis

Posted on: 03/11/2014 - 19:36

LAS VEGAS – A twice-daily 30-mg dose of apremilast significantly improved moderate to severe nail, scalp, and palmoplantar psoriasis, compared with placebo, based on data from 411 adults in the...

Field of Interest: Dermatology

Type: News Item

Biosimilars poised to make biologics more routine

Posted on: 16/10/2014 - 13:00

The biosimilar age for rheumatology has arrived, and experts expect wider use of previously expensive biologic drugs as biosimilar competition drives prices down and makes biologics more...

Field of Interest: Rheumatology

Type: News Item

Musculoskeletal ultrasound increased diagnostic certainty in inflammatory arthritis

Posted on: 09/10/2014 - 21:27

Musculoskeletal ultrasound was associated with more than double gains in diagnostic certainty in a prospective cohort of consecutive patients referred for the evaluation of inflammatory...

Field of Interest: Rheumatology

Type: News Item

Apremilast approval expanded to include plaque psoriasis

Posted on: 24/09/2014 - 20:48

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology

Type: News Item

Anti-adalimumab antibodies mean poorer outcomes in psoriatic arthritis

Posted on: 22/08/2014 - 17:35

Psoriatic arthritis patients with detectable anti-adalimumab antibodies have significantly lower serum adalimumab concentrations and poorer clinical outcomes at 28 weeks and 52 weeks of treatment,...

Field of Interest: Dermatology

Type: News Item

Anti-adalimumab antibodies mean poorer outcomes in psoriatic arthritis

Posted on: 22/08/2014 - 17:35

Psoriatic arthritis patients with detectable anti-adalimumab antibodies have significantly lower serum adalimumab concentrations and poorer clinical outcomes at 28 weeks and 52 weeks of treatment,...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters